SLYND is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Exeltis Usa, Inc.. The primary component is Drospirenone.
| Product ID | 0642-7470_0cdabfc8-f647-42d8-bd85-da6e8a875f24 | 
| NDC | 0642-7470 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | SLYND | 
| Generic Name | Drospirenone | 
| Dosage Form | Tablet, Film Coated | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2019-06-06 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA211367 | 
| Labeler Name | Exeltis USA, Inc. | 
| Substance Name | DROSPIRENONE | 
| Active Ingredient Strength | 4 mg/1 | 
| Pharm Classes | Progesterone Congeners [CS],Progestin [EPC] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2020-12-31 | 
| Marketing Start Date | 2019-09-01 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA211367 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2019-09-01 | 
| Marketing Category | NDA | 
| Application Number | NDA211367 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2019-09-01 | 
| Marketing Category | NDA | 
| Application Number | NDA211367 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2019-06-06 | 
| Marketing Category | NDA | 
| Application Number | NDA211367 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2019-09-01 | 
| Ingredient | Strength | 
|---|---|
| DROSPIRENONE | 4 mg/1 | 
| SPL SET ID: | db32bc55-f295-4d87-9dbb-0a2f45573dcf | 
| Manufacturer | |
| UNII | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() SLYND  88802490  not registered Live/Pending  | 
        Chemo Research, S.L.  2020-02-19  | 
![]() SLYND  88274384  not registered Live/Pending  | 
        CHEMO RESEARCH, S.L.  2019-01-24  |